We collect and use information about you, your devices and interactions to improve our services. For more information about how we collect your personal information and our use of cookies on our website, please see our Privacy Policy.

Annalise CXR to be used at over 300 radiology clinics following Sonic Imaging implementation

24.09.21

Annalise CXR, a comprehensive decision-support solution that helps radiologists and clinicians to detect 124 findings on chest x-ray studies, will be used by over 300 sites nationwide, following Sonic Imaging Australia’s decision to implement the solution at its 100 clinics across the country. 

Sonic Imaging CEO Julian Adler commented: “Following a thorough market scan we chose annalise.ai to become our preferred decision support AI provider.  We determined that the Annalise Enterprise Platform is category leading in its comprehensiveness and offers Sonic the premier AI platform we are seeking for chest x-ray, with a strong roadmap across multiple modalities.

The fact that radiologists and clinicians are heavily involved in solutions development and deployment is obvious, resulting in an intuitive product that radiologists appreciate. The implementation of the Annalise Enterprise Platform contributes to our ongoing commitment to patient safety and reporting quality at Sonic Imaging Australia.”

Annalise CXR will now be available at Sonic Imaging Australia’s stand-alone clinics and at some of the country’s leading hospitals, including the Epworth Hospitals in Melbourne and Geelong, the Mater Hospitals in Brisbane and regional Queensland, the Greenslopes Hospital, the QEII Jubilee, Sunnybank, Gold Coast Private and St Vincent’s Toowoomba Hospitals, also in Queensland and at the St John of God’s Hospitals in Subiaco and Murdoch in Western Australia. 

annalise.ai CEO Dimitry Tran said: “Annalise CXR is now available to over 30% of radiologists in Australia, through a number of Australian imaging networks providing patients access to the most comprehensive AI chest x-ray solution in the world”

“We are proud to offer the Australian community this extra layer of clinical care and look forward to scaling up as we enter the European and Asian markets this year.”

Annalise CXR is a comprehensive AI solution that is available for clinical use in Australia, New Zealand, the UK, Malaysia and is CE marked for use as a medical device in the EU.  

The launch of Annalise CXR coincided with its publication of a peer-reviewed diagnostic accuracy study published by The Lancet Digital Health, which was the largest of its kind ever undertaken in terms of the number of findings concurrently evaluated.

The study assessed the standalone performance of the model in a non-clinical environment against radiologists in identifying chest x-ray findings. It also investigated the effect of model output on radiologist performance when used as an assist device.

The study found that when used as an assist device in a non-clinical environment, Annalise CXR significantly improved the ability for radiologists to detect 102 chest X-ray (CXR) findings. Radiologist performance change was statistically non-inferior for 19 other findings and did not significantly drop when assisted by the model for any of the 124 findings. 

Annalise CXR’s AI model classification alone was significantly more accurate than unassisted radiologists for 117 of 124 clinical findings predicted by the model and was non-inferior to unassisted radiologists for all other clinical findings. Typically, other CXR AI products on the market are limited to fewer than 15 findings.

Sonic Imaging Australia’s services are overseen by more than 200 specialist radiologists and nuclear physicians, many of whom have sub-specialty expertise. They are supported by highly trained and experienced technical and clerical practice staff who are focused on providing the best service, care and clinical outcomes for doctors and their patients.

Never miss an update.

Subscribe to our newsletter.